Market revenue in 2023 | USD 107.3 million |
Market revenue in 2030 | USD 170.6 million |
Growth rate | 6.8% (CAGR from 2023 to 2030) |
Largest segment | Non-personal promotion |
Fastest growing segment | Non-personal promotion |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Personal Promotion, Non-personal promotion |
Key market players worldwide | Mobico Group PLC, IQVIA Holdings Inc, CMiC, EPS CORP, QFR Solutions, Mednext Pharma, Peak Pharma, Promoveo Health, Syneos Health |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to pharmaceutical contract sales organizations market will help companies and investors design strategic landscapes.
Non-personal promotion was the largest segment with a revenue share of 55.45% in 2023. Horizon Databook has segmented the South Africa pharmaceutical contract sales organizations market based on personal promotion, non-personal promotion covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of country-level data and insights on the South Africa pharmaceutical contract sales organizations market , including forecasts for subscribers. This country databook contains high-level insights into South Africa pharmaceutical contract sales organizations market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account